Recombinant factor VIIa reduces bleeding in severely thrombocytopenic rabbits

Thrombosis Research

Volumn 109, Issue 4, 2003, Pages 217-223

  Tranholm, Mikael ^a   Rojkjaer, Rasmus ^a   Pyke, Charles ^a   Kristensen, Annemarie T ^c   Klitgaard, Birgitte ^a   Lollike, Karsten ^a   Blajchman, Morris A ^b  

^a NOVO NORDISK A S   (Denmark)

^b MCMASTER UNIVERSITY   (Canada)

^c NONE

Author keywords

Bleeding model; Rabbits; rFVIIa; Thrombocytopenia; Thromboelastography

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOCYTE ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; BLEEDING TIME; BLOOD CLOTTING; CONTROLLED STUDY; CUTICLE; DISEASE SEVERITY; DRUG EFFECT; GAMMA IRRADIATION; HISTOPATHOLOGY; IN VITRO STUDY; KIDNEY BIOPSY; NAIL; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RABBIT; THROMBOCYTOPENIA; THROMBOELASTOGRAPHY;

EID: 0037837277     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00146-4     Document Type: Article

References (30)

1. Gelb A.B., Leavitt A.D. Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to random selected platelets. Transfusion. 37:1997;624-630.
2. George J.N., Mujahid A.R. Diagnosis and management of thrombocytopenia. Colman R.W., Hirsh J., Marder V.J., Clowes A.W., George J.N. Hemostasis and thrombosis. Basic principles & clinical practice. 2001;1021-1031 Lippencott Williams & Wilkins, Philadelphia.
3. Goldman M., Blajchman M.A. Bacterial contamination of platelets. Seghatchian L., Snyder E.L., Kraliadsiri P. Platelet therapy. 2000;401-414 Elsevier, Amsterdam.
4. Shapiro A.D., Gilchrist G.S., Hoots W.K., Cooper H.A., Gastineau D.A. Prospective, randomized trial of two doses of rFVIIa (NovoSeven) in hemophilia patients with inhibitors undergoing surgery. Thromb. Haemost. 80(5):1998;773-778.
5. Ingerslev J., Thykjaer H., Scheibel E. Approaches towards successful home treatment in patients with inhibitors. Eur. J. Haematol. 61:1998;11-14.
6. Scharrer I. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency. Haemophilia. 5(4):1999;253-259.
7. Lusher J.M., Roberts H.R., Davignon G., Joist J.H., Smith H., Shapiro A.et al. A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. Haemophilia. 4(6):1998;790-798.
8. Monroe D.M., Hoffman M., Oliver J.A., Roberts H.R. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br. J. Haematol. 99:1997;542-547.
9. Butenas S., Brummel K.E., Branda R.F., Paradis S.G., Mann K.G. Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood. 99:2002;923-930.
10. Hoffman M., Monroe D.M., Roberts H.R. Platelet-dependent action of high-dose factor VIIa. Blood. 100:2002;364-365.
11. Mann K.G., Butenas S. Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood. 100:2002;365.
12. Hedner U. Recombinant factor VIIa (NovoSeven (R)) as a hemostatic agent. Semin. Hematol. 38(4):2001;43-47.
13. Friedrich F.W., Christiaan P.H., Messelink E.J., Geerdink M.G., Keller T., Kurth K.H.et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomized trial. Lancet. 361:2003;201-205.
14. Kristensen J., Killander A., Hippe E., Helleberg C., Ellegaard J., Holm M.et al. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis. 26(1):1996;159-164.
15. Gerotziafas G.T., Zervas C., Gavrielidis G., Tokmaktsis A., Hatjiharissi E., Papaioannou M.et al. Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. Am. J. Hematol. 69:2002;219-222.
16. Poon M.C., Demers C., Jobin F. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thromboasthenia. Blood. 94:1999;3951-3953.
17. Blajchman M.A., Lee D.H. The thrombocytopenic rabbit bleeding time model to evaluate the in vivo hemostatic efficacy of platelets and platelet substitutes. Transfus. Med. Rev. 11:1997;95-105.
18. Olfert E.D., Cross B.M., McWilliam A.A. Guide to the care and use of experimental animals. 1993;Canadian Council on Animal Care, Ottawa, Ontario, Canada.
19. Erhardtsen E., Ezban M., Madsen M.T., Diness V., Glazer S., Hedner U.et al. Blocking of tissue factor pathway inhibitor (tfpi) shortens the bleeding-time in rabbits with antibody-induced hemophilia-A. Blood Coagul. Fibrinolysis. 6:1995;388-394.
20. Wildgoose P., Nemerson Y., Hansen L.L., Nielsen F.E., Glazer S., Hedner U. Measurement of basal levels of factor VIIa in hemophilia A and B patients. Blood. 80:1992;25-28.
21. Kjalke M., Oliver J.A., Monroe D.M., Hoffman M., Ezban M., Hedner U.et al. The effect of active site-inhibited factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin administration. Thromb. Haemost. 78:1997;1202-1208.
22. Bancroft J.D., Stevens A. Theory and practice of histological techniques. 1996;107-109 Churchill Livingstone, New York.
23. Kristensen A.T., Madsen M.T., Nielsen G.N., Ezban M. Recombinant human FVIIa dose dependently shortens the bleeding time in a rabbit model of antibody induced hemophilia A. Thromb. Haemost. 1999;1038.
24. Hedner U., Bergqvist D., Ljungberg J., Nilson B. Haemostatic effect of factor VIIa in thrombocytopenic rabbits. Blood. 66(1):1985;1043.
25. Kristensen A.T., Ezban M., Villumsen A., Bregengaard C. Pharmakokinetics, and effect of peptido-chloro-methyl-ketone inactivated recombinant Factor VIIa molecules on dilute tissue factor clotting time and activated partial thromboplastin time in rabbits. Thromb. Haemost. 73:1995;1322.
26. Elg M., Carlsson S., Gustafsson D. Effects of agents, used to treat bleeding disorders, on bleeding time prolonged by a very high dose of a direct thrombin inhibitor in anesthesized rats and rabbits. Thromb. Res. 101:2001;159-170.
27. Kuter D.J., Rosenberg R.D. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood. 85(10):1995;2720-2730.
28. Kjalke M., Johannessen M., Hedner U. Effect of recombinant factor VIIa (Novoseven) on thrombocytopenia-like conditions in vitro. Semin. Hematol. 38:2001;15-20.
29. Kawaguchi C., Takahashi Y., Hanesaka Y., Yoshioka A. The in vitro analysis of the coagulation mechanism of activated factor VII using thrombelastogram. Thromb. Haemost. 88:2002;768-772.
30. Hendriks H.G.D., Meijer K., de Wolf J.T.M., Porte R.J., Klompmaker I.J., Lip H.et al. Effects of recombinant activated factor VII on coagulation measured by thromboelastography in liver transplantation. Blood Coagul. Fibrinolysis. 13:2002;309-313.